VAN-10-4-eluting stent (University of Strathclyde)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameVAN-10-4-eluting stent (University of Strathclyde)
Drug Alias NameINC-105-eluting stent (Inncardio/University of Strathclyde)Marigold compound (Inncardio/University of Strathclyde)
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionMitogen-activated protein kinase inhibitors
TargetsMitogen-activated protein kinase
Therapy Area/IndicationsCoronary Restenosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Strathclyde
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLong-E InternationalUniversity Of Strathclyde
Active IndicationsN/A
Inactive IndicationsCoronary Restenosis

Other Information

ATC CodeN/A
Related LinksN/A